Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
1 Oct 2015
Lifestyle Intervention Programme : Multidisciplinary Approach Increased Compliance by 450%
The Specialist Health Centre, an organisation working alongside the Essex primary and secondary care trusts, has recently responded to the demand for…
28 Sep 2015
Psychological Factors Affect Gastrointestinal Infections
ANXIETY increases the risk of gastrointestinal infection and long-term complications, according to the results of an investigation of a…
28 Sep 2015
Breakthrough Experimental Therapy Treats Colon Cancer and Chronic Inflammatory Bowel Disease
SCIENTISTS have discovered a groundbreaking experimental therapy that is capable of suppressing the development of ulcerative colitis (UC)…
25 Sep 2015
European CHMP Adopts Positive Opinion for Gilead’s Single Tablet Regimen Genvoya® (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide) for the Treatment of HIV
Foster City, CA, September XX, 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP)…
24 Sep 2015
NICE Recommends Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukaemia
London, 24 September 2015 – Gilead Sciences’ Zydelig® (idelalisib) has today been recommended by the National Institute for Health and Care Excellence…
21 Sep 2015
Gout Medications May Be Effective In Treating Alcohol-Induced Liver Disease
COMMONLY used gout medications could offer protection from alcohol-induced liver disease and inflammation, according to the results of new research in mice.
21 Sep 2015
Liver Failure: Stem Cell Therapy Could Replace Liver Transplantation
STEM cell therapy could one day replace liver transplantation as the primary treatment for liver failure, according to a study which saw researchers…
15 Sep 2015
NITID (Optical Coherence Tomography and Digital Dermatoscope Handheld Device) – CE Mark Approval Received
Madrid, September 10, 2015. DermaLumics, a recently founded spin-off of optical tomography systems developer MedLumics, announces that NITID…
15 Sep 2015
Genomic testing for breast cancer in the neoadjuvant setting
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hope S. Rugo, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center…
15 Sep 2015
Introducing the Oncotype DX® Breast Cancer Assay and its impact in clinical practice
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Mohammed Jaloudi, MD, of Tawam Hospital, Al Ain, United Arab Emirates, discusses…
←
1
2
3
…
937
938
939
940
941
942
943
…
1,019
1,020
1,021
→